Autonomix Medical, Inc. (AMIX) stock surged over 100% on Monday after the company announced promising preliminary results from its ongoing human trial evaluating a new treatment for pancreatic cancer pain. The trial, which utilizes a catheter-based microchip sensing array antenna to target and ablate pain-causing nerves, showed significant pain reduction and opioid elimination in patients treated with femoral access.
MIRA Pharmaceuticals Inc. saw its stock surge after revealing promising preclinical data for its lead development product, Ketamir-2. This novel oral Ketamine analog achieved a 100% reversal of neuropathic pain in preclinical models, potentially offering a significant advancement in pain management. The company is aiming for human trials by 2025.
A new study by Tilray Medical, a division of Tilray Brands, shows positive results in using cannabinoid treatments for patients with fibromyalgia. The study, titled ‘Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS),’ examined the impact of Tilray Dried Flower THC18 on chronic pain, sleep, and quality of life. The findings suggest that cannabinoids could be a promising and cost-effective treatment option for fibromyalgia patients.
Two recent studies highlight the potential benefits of cannabis and CBD in managing symptoms for patients with endometriosis and daytime fatigue. One study found that cannabis was effective in reducing pain and improving sleep quality for endometriosis patients, while another study showed that CBD reduced daytime fatigue and improved psychological well-being.
The NFL and NCAA are making significant moves towards embracing cannabis, driven by groundbreaking research highlighting its potential benefits for athletes. This shift reflects a growing understanding of cannabis’s therapeutic applications, particularly in pain management and recovery. The NFL’s investment in cannabinoid studies and the NCAA’s removal of cannabis from its banned substances list signal a potential paradigm shift in the world of sports.
A recent study published in Heliyon explores the potential therapeutic applications of LSD, revealing its impact on brain regions associated with pain processing. The research, conducted by Hamid Sharini and his team at Kermanshah University of Medical Sciences, utilized fMRI to analyze brain activity in healthy volunteers under the influence of LSD. The findings suggest that LSD alters pain perception by reducing activity in pain-processing regions and disrupting connectivity patterns between brain areas involved in the emotional and cognitive aspects of pain. While promising, further research is needed to understand the long-term implications and potential benefits of LSD for pain management.
Northumberland Hills Hospital has launched a new palliative and supportive care division and appointed Dr. Francesco Mulé as its head of service. The division will build upon the hospital’s existing six-bed palliative care unit and aims to provide comprehensive end-of-life care and pain management for patients and families. Dr. Mulé, who has been with the hospital since 2011, will leverage his experience in emergency medicine and palliative care to enhance the new division’s services. The hospital will also establish a Palliative and Supportive Care Quality Practice Committee (QPC) to ensure transparency and structure in reporting on palliative care services.
Difficulty swallowing, known as dysphagia, can be a symptom of eosinophilic esophagitis, an immune-mediated condition. A study has shown that eliminating cow’s milk products from the diet can effectively control the disease. For trigeminal neuralgia, a painful facial condition, medications are the usual first-line treatment, with surgical or radiation options available if medications fail.
A recent study from the University of South Australia highlights the importance of pain education for individuals experiencing pelvic pain. The study found that education about the nature of pain and how it works can help women better manage their pain and improve their overall outcomes.
